This health issue relies on tremor-free Ronald Reagan's "Trust but verify." As Russia took down the wall, so too did citizen activists take the lead out of gasoline and smog out of the skies.
In the early 1970s, the advantages of adding a dopa decarboxylase inhibitor to treat Parkinson's Disease (PD) were discovered, seemingly gaining better PD-symptom control.
The first levodopa combination, carbidopa/levodopa, became commercially available in 1975. Here's information Doctor Google offers to those curious enough to hunt for good lobbyist free health advice. My preferences for these visits include the Mayo and Cleveland Clinics, National Institutes of Health, Web MD, etc. Ask Google yourself.
What are two major problems with levodopa?
Side effects
The most common side effects of levodopa are nausea, sleepiness, dizziness, and headache. More serious side effects can include confusion, hallucinations, delusions, agitation, and psychosis; these are more common in older people.
What are the long-term side effects of levodopa?
It has been clarified that long-term levodopa therapy in Parkinson's disease may pose various serious problems of adverse reactions, such as dyskinesia, wearing-off effect, on-off effect, mental symptoms, and frozen gait.
Dyskinesias usually begin after a few years of treatment with levodopa, the most prescribed PD medicine.
What triggers dyskinesia?
Dyskinesia is most caused by medications, such as long-term use of levodopa in Parkinson's disease and use of antipsychotic medications.
Pharma companies spent $390 million on federal and state lobbying in 2021.
The health sector's spending on federal lobbying rose 70% from 2000 to 2020, driven mostly by pharmaceutical and health product manufacturers and providers, visibly presented by well-paid and expensively dressed lobbyists prowling congressional halls...
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
